By Alexander Winning, Olivia Kumwenda-Mountambo JOHANNESBURG (Reuters) – South Africa has used AstraZeneca’s COVID-19 shot in its vaccination program, after data showed it provided minimal protection against mild to moderate infections caused …
Read More »
By Alexander Winning, Olivia Kumwenda-Mountambo JOHANNESBURG (Reuters) – South Africa has used AstraZeneca’s COVID-19 shot in its vaccination program, after data showed it provided minimal protection against mild to moderate infections caused …
Read More »
By Derek Francis, Andy Bruce (Reuters) – British drugmaker AstraZeneca AZN.L Its vaccine, developed on Saturday with Oxford University, provided only limited protection from mild disease caused by the South African version …
Read More »
By Derek Francis, Andy Bruce (Reuters) – British drugmaker AstraZeneca AZN.L Its vaccine, developed on Saturday with Oxford University, provided only limited protection from mild disease caused by the South African version …
Read More »
By Derek Francis, Andy Bruce (Reuters) – British drugmaker AstraZeneca AZN.L Its vaccine, developed on Saturday with Oxford University, provided only limited protection from mild disease caused by the South African version …
Read More »
(Reuters) – The Biden administration is exploring every option to increase manufacturing of Johnson & Johnson’s COVID-19 vaccine, which is under regulatory review, and said Friday that the initial dose level is …
Read More »
LONDON (Reuters) – The UK on Thursday launched a trial to assess immune responses generated if doses of COVID-19 vaccines from Pfizer Inc and AstraZeneca plc are combined on a two-shot schedule. …
Read More »
LONDON (Reuters) – The UK on Thursday launched a trial to assess immune responses generated if doses of COVID-19 vaccines from Pfizer Inc and AstraZeneca plc are combined on a two-shot schedule. …
Read More »
(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective at stopping COVID-19 in a large global trial against several variants, giving health officials another weapon to …
Read More »
SYDNEY (Reuters) – Australia on Monday approved the Pfizer-BioNotech COVID-19 vaccine for use, but warned of AstraZeneca’s international production problems, which means the country has a planned local built The shot will …
Read More »